✦ LIBER ✦

26 – Remission in patients with schizophrenia treated with risperidone long-acting injection (RLAI)

✍ Scribed by J. Peuskens; M. Povey; J. Van Der Veken; A. Jacobs

Book ID: 119363452
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 98
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2007.12.093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFICACY AND TOLERABILITY AMONG PATIENTS

EFFICACY AND TOLERABILITY AMONG PATIENTS WITH RECENT ONSET SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG-ACTING INJECTABLE (RLAI)

✍ Oleksandr Napryeyenko; Benjaminas Burba; Guadalupe Martinez; Nikolay Neznanov; T 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Remission in schizophrenia: 1 year Itali

Remission in schizophrenia: 1 year Italian study with risperidone long-acting injectable (RLAI) in subjects with schizophrenia or schizoaffective disorder

✍ A. Rossi; M.M. Bernareggi; M.G. Giustra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 42 KB

Remission in schizophrenia: one-year Ita

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder

✍ Alessandro Rossi; Anna Bagalà; Vincenzo Del Curatolo; Francesco Scapati; Micaela 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone long‐acting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac

Substance abuse (SA) does not compromise

Substance abuse (SA) does not compromise significant improvements in spanish patients with schizophrenia treated with risperidone long-acting injection (RLAI)

✍ J.M. Olivares; A. Rodriguez; J.A. Buron; A. Rodriguez-Morales; M. Povey; A. Jaco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 46 KB

COMPARING risperidone long-acting inject

COMPARING risperidone long-acting injection (RLAI) with oral antipsychotics in Spanish patients with schizophrenia using propensity scoring

✍ J. Diels; J.M. Olivares; A. Rodriguez-Morales; S. Caleo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 57 KB

Improvements in illness severity and fun

Improvements in illness severity and functioning in Australian schizophrenia patients treated with risperidone long-acting injection (RLAI) for 12 months

✍ H. Hustig; T. Lambert; B. Emmerson; M. Povey; A. Jacobs; C. Methven 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 46 KB